- Home
- BOX vs KYMR Comparison
BOX vs KYMR Comparison
Compare BOX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | KYMR |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.7B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOX | KYMR |
|---|---|---|
| Price | $31.27 | $87.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 22 |
| Target Price | $38.80 | ★ $96.32 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 12-02-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.13 | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $1,150,898,000.00 | $43,735,000.00 |
| Revenue This Year | $8.89 | $20.81 |
| Revenue Next Year | $7.58 | N/A |
| P/E Ratio | $25.24 | ★ N/A |
| Revenue Growth | ★ 7.21 | N/A |
| 52 Week Low | $28.00 | $19.45 |
| 52 Week High | $38.80 | $103.00 |
Technical Indicators
Market Signals| Indicator | BOX | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 72.08 |
| Support Level | $31.04 | $64.84 |
| Resistance Level | $32.76 | $103.00 |
| Average True Range (ATR) | 1.06 | 4.10 |
| MACD | 0.23 | 2.06 |
| Stochastic Oscillator | 63.13 | 58.06 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.